Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
Stroke and Vascular Neurology

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
Open Access

Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial

DOI: 10.1136/svn-2021-001480corr1 Published 25 August 2023
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 8 no. 4 e2
DOI 
https://doi.org/10.1136/svn-2021-001480corr1
PubMed 
36810212

Print ISSN 
2059-8688
Online ISSN 
2059-8696
History 
  • Published online August 25, 2023.

Article Versions

  • Previous version (February 21, 2023 - 04:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Author Information

View Full Text

Article usage

Article usage: February 2023 to May 2025

AbstractFullPdf
Feb 2023717323
Mar 2023858538
Apr 2023767716
May 2023878714
Jun 202384847
Jul 2023808019
Aug 202317217229
Sep 202322222146
Oct 202324424431
Nov 202314514516
Dec 2023848411
Jan 2024555512
Feb 2024717110
Mar 2024616136
Apr 2024414115
May 202442438
Jun 2024242313
Jul 2024322918
Aug 2024161513
Sep 2024252513
Oct 202423235
Nov 202412124
Dec 2024110
Apr 20250412
May 202501690

Statistics from Altmetric.com

PreviousNext
Back to top
Vol 8 Issue 4 Table of Contents
Stroke and Vascular Neurology: 8 (4)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Front Matter (PDF)
Email

Thank you for your interest in spreading the word on Stroke and Vascular Neurology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
(Your Name) has sent you a message from Stroke and Vascular Neurology
(Your Name) thought you would like to see the Stroke and Vascular Neurology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
Stroke and Vascular Neurology Aug 2023, 8 (4) e2; DOI: 10.1136/svn-2021-001480corr1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
Stroke and Vascular Neurology Aug 2023, 8 (4) e2; DOI: 10.1136/svn-2021-001480corr1
Download PDF

Share
Correction: Indobufen versus aspirin in acute ischaemic stroke (INSURE): rationale and design of a multicentre randomised trial
Stroke and Vascular Neurology Aug 2023, 8 (4) e2; DOI: 10.1136/svn-2021-001480corr1
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
  • Correction: Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS
Show more Correction

Similar Articles

 
 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • eLetters
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Recommend to librarian
  • Chinese Stroke Association

AUTHORS

  • Instructions for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2025 Chinese Stroke Association